Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2015-08-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/ATVBAHA.115.305614PMID 26315407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia

  2015cited by this paper
• Hypertriglyceridemia in the genomic era: a new paradigm.

  2015cited by this paper
• Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

  2014cited by this paper
• Physiological regulation of lipoprotein lipase.

  2014cited by this paper
• Type 2 diabetes and cardiovascular disease: what next?

  2014cited by this paper
• Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

  2014cited by this paper
• Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease

  2014cited by this paper
• The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.

  2014cited by this paper
• Regulation of lipoprotein lipase by Angptl4.

  2014cited by this paper
• Targeting APOC3 in the familial chylomicronemia syndrome.

  2014cited by this paper
• Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.

  2014cited by this paper
• Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

  2013cited by this paper
• Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets*

  2013cited by this paper
• Angiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase

  2013cited by this paper
• A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

  2012cited by this paper
• Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism

  2012cited by this paper
• Apolipoprotein B-100–Containing Lipoprotein Metabolism in Subjects With Lipoprotein Lipase Gene Mutations

  2012cited by this paper
• Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.

  2011cited by this paper
• Apolipoprotein CIII: 42 years old and even more interesting.

  2011cited by this paper
• Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects

  2011cited by this paper
• Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.

  2011cited by this paper
• Complexities of plasma apolipoprotein C-III metabolism1

  2011cited by this paper
• Apolipoproteins: metabolic role and clinical biochemistry applications

  2011cited by this paper
• Hepatic lipase, high density lipoproteins, and hypertriglyceridemia.

  2011cited by this paper
• Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women.

  2010cited by this paper
• Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity.

  2010cited by this paper
• Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins

  2010cited by this paper
• Triglyceride lipases and atherosclerosis

  2010cited by this paper
• Lipoprotein lipase: from gene to obesity.

  2009cited by this paper
• Molecular processes that handle -- and mishandle -- dietary lipids.

  2008cited by this paper
• Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency.

  2008cited by this paper
• Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

  2007cited by this paper
• Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractionss⃞ Published, JLR Papers in Press, February 21, 2007.

  2007cited by this paper
• Lipoprotein Lipase Bound to Apolipoprotein B Lipoproteins Accelerates Clearance of Postprandial Lipoproteins in Humans

  2006cited by this paper
• Overproduction of large VLDL particles is driven by increased liver fat content in man

  2006cited by this paper
• Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.

  2006cited by this paper
• Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics

  2005cited by this paper
• Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

  2005cited by this paper
• A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400108-JLR200

  2005cited by this paper
• Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

  2005cited by this paper
• Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells.

  2005cited by this paper
• LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.

  2002cited by this paper
• Lipoprotein lipase Published, JLR Papers in Press, October 1, 2002. DOI 10.1194/jlr.R200015-JLR200

  2002cited by this paper
• Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.

  1999cited by this paper
• SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

  1998cited by this paper
• Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.

  1996cited by this paper
• Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins.

  1996cited by this paper
• Heparin-decasaccharides impair the catabolism of chylomicrons.

  1996cited by this paper
• Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP).

  1994cited by this paper
• Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.

  1993cited by this paper
• Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.

  1991cited by this paper
• Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration.

  1989cited by this paper
• Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.

  1988cited by this paper
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

  1986cited by this paper
• Association of plasma lipoproteins with postheparin lipase activities.

  1986cited by this paper
• Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

  1985cited by this paper
• Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.

  1982cited by this paper
• Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.

  1976cited by this paper
• An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma.

  1975cited by this paper
• Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources.

  1973cited by this paper
• Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.

  1972cited by this paper
• Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart.

  1955cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to

  year unknowncited by this paper

• Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target

  2026cites this paper
• Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes

  2025cites this paper
• Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025

  2025cites this paper
• Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study

  2025cites this paper
• "Induction of obesity by a high-carbohydrate diet in zebrafish modulates genes related to feeding behavior and inflammation".

  2025cites this paper
• Genetic Evidence for Causal Effects of circulating remnant lipid profile on cerebral hemorrhage and ischemic stroke: A Mendelian Randomization Study.

  2025cites this paper
• Anti-Obesity Effect of Jeju Roasted Citrus Peel Extract in High-Fat Diet-Induced Obese Mice and 3T3-L1 Adipocytes Via Lipid Metabolism Regulation

  2024cites this paper
• Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk

  2024cites this paper
• Plasma metabolites, systolic blood pressure, lifestyle, and stroke risk: A prospective cohort study

  2024cites this paper
• Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes

  2024cites this paper
• Trigliceridos mayores a 100mg/dl en relación a valores postprandiales, HOMA, No- HDL y Colesterol Remanente

  2024cites this paper
• Biosynthesis and Metabolism of ApoB-Containing Lipoproteins.

  2024cites this paper
• Exploring apolipoprotein C-III: Pathophysiological and pharmacological relevance.

  2023cites this paper
• Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment

  2022cites this paper
• Association between metabolic syndrome and left ventricular geometric change including diastolic dysfunction

  2022cites this paper
• Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia

  2022cites this paper
• Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations

  2022cites this paper
• The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets

  2022cites this paper
• Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases

  2021cites this paper
• Lipoproteins in the postprandial state

  2021cites this paper
• Lean adolescents with insulin resistance display higher angiopoietin like protein 3, ApoC-III and chylomicron remnant dyslipidemia.

  2021cites this paper
• Enyzmes | Lipoprotein Lipase

  2021cites this paper
• Metabolism of Triglyceride-Rich Lipoproteins.

  2021influential citation
• Unravelling Lipoprotein Metabolism with Stable Isotopes: Tracing the Flow.

  2021cites this paper
• Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans

  2021cites this paper
• Triglycerides and cardiovascular disease

  2021cites this paper
• Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans

  2020influential citation
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  2020cites this paper
• Diets with low n-6:n-3 PUFA ratio protects rats from fructose-induced dyslipidemia and associated hepatic changes: Comparison between 18:3 n-3 and long-chain n-3 PUFA.

  2020cites this paper
• Causes and Consequences of Hypertriglyceridemia

  2020cites this paper
• Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia

  2020cites this paper
• The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

  2020cites this paper
• Hypertriglyceridemia—Causes, Significance, and Approaches to Therapy

  2020cites this paper
• Dysregulated lipid metabolism links NAFLD to cardiovascular disease

  2020cites this paper
• ApoCIII: A multifaceted protein in cardiometabolic disease.

  2020cites this paper
• The Effect of Soy Milk and Boiled Peas to Waist Circumference in Postmenopausal Women

  2020cites this paper
• The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

  2020cites this paper
• Differences in lipoprotein profiles between Palestinian 1 and Israeli Adults 2 3

  2020cites this paper
• Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

  2019cites this paper
• The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

  2019cites this paper
• Regulation of Lipoprotein Lipase Activity : an In-vitro Study of a Complex and Dynamic System

  2019cites this paper
• A higher glycemic response to oral glucose is associated with higher plasma apolipoprotein C3 independently of BMI in healthy twins.

  2019cites this paper
• Dietary Fructose and the Metabolic Syndrome

  2019cites this paper
• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

  2019cites this paper
• Diabetes, Triglycerides and Atherosclerosis

  2019cites this paper
• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

  2019cites this paper
• Triglyceride lowering 2.0: back to the future?

  2019cites this paper
• Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

  2019cites this paper
• LDL Cholesterol Rises With BMI Only in Lean Individuals: Cross-sectional U.S. and Spanish Representative Data

  2018cites this paper
• Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables

  2018cites this paper
• SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids

  2018cites this paper
• Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized controlled study

  2018cites this paper
• Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism[S]

  2018cites this paper
• More pieces of the fructose puzzle

  2017cites this paper
• Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

  2017cites this paper
• Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease

  2017cites this paper
• Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Identification and targeting of genes in atherosclerosis

  2017cites this paper
• Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study

  2017cites this paper
• Interpreting lipoproteins in nonalcoholic fatty liver disease

  2017cites this paper
• Pathophysiology of Diabetic Dyslipidaemia.

  2017cites this paper
• Kinetics of plasma triglycerides in abdominal obesity

  2016cites this paper
• Triglycerides to high-density lipoprotein–cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes

  2016cites this paper
• Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

  2016cites this paper
• The effect of exercise in NAFLD and a GLP-1 receptor agonist in type 2 diabetes on lipid metabolism.

  2016cites this paper
• The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity

  2016cites this paper
• Role of lipoprotein lipase in lipid metabolism

  2016cites this paper
• Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism

  2016cites this paper
• Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

  2016cites this paper
• Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.

  2016cites this paper
• Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

  2015influential citation
• Hypertriglyceridemia Associated With Abdominal Obesity: Getting Contributing Factors Into Perspective.

  2015cites this paper
• Fasting and nonfasting triglycerides in cardiovascular and other diseases.

  2015cites this paper
• Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.

  2014cites this paper
• Carpentier Into Perspective Hypertriglyceridemia Associated With Abdominal Obesity : Getting Contributing Factors

  year unknowncites this paper